DiPietro Kenneth

1.4

1.4

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Download results Settings

Cerevel Therapeutics Holdings Inc (CERE)

Transaction date 22 Dec 2023

Sale

Price

433.00

Quantity 9,716 +45.9%

Value US$4,019,932

Comments Filing

Cerevel Therapeutics Holdings Inc (CERE)

Transaction date 22 Dec 2023

Proposed sale

Price

10.53

Quantity 25,772

Value US$3,840,965

Cerevel Therapeutics Holdings Inc (CERE)

Transaction date 20 Dec 2023

Sale

Price

210.73

Quantity 57,541 +28.5%

Value US$42,659

Comments Filing

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2023-12-27	2023-12-22	Cerevel Therapeutics Holdings Inc (CERE)	S Sale	9,716 +45.9% 433.00 US$4,019,932	9,716 +45.9%	433.00	US$4,019,932
2023-12-22	2023-12-22	Cerevel Therapeutics Holdings Inc (CERE)	PrS Proposed sale	25,772 10.53 US$3,840,965	25,772	10.53	US$3,840,965
2023-12-21	2023-12-20	Cerevel Therapeutics Holdings Inc (CERE)	S Sale	57,541 +28.5% 210.73 US$42,659	57,541 +28.5%	210.73	US$42,659